Literature DB >> 10789703

Predictive value of preoperative serum cholinesterase concentration in patients with liver dysfunction undergoing cardiac surgery.

N Hirata1, Y Sawa, H Matsuda.   

Abstract

OBJECTIVE: There are an increasing number of patients with severe liver dysfunction subjected to open heart surgery. This retrospective study was designed to assess operative results and clarify the degree of liver injury in patients with liver dysfunction undergoing open heart surgery. In addition, determinants influencing their prognosis were assessed.
METHODS: In a 9-year period from 1988 to 1996, we operated on 31 patients with posthepatitis liver dysfunction and 16 with chronic passive congestion of the liver. This group was 2.3% and 1.6% of the 1368 patients undergoing cardiac surgery in the same period. We compared several perioperative factors between survivors and nonsurvivors to determine risk factors affecting mortality.
RESULTS: In the group with posthepatitis liver dysfunction, the postoperative course of 5 patients among 31 (16.1%) was poor. Serum cholinesterase concentration was lower only in the nonsurvivor group (nonsurvivor vs survivor: 1979+/-949 vs 3515+/-1424 IU/I, p < 0.05). All patients with cholinesterase < 2000 IU/L died. The duration of CPB (212+/-53 vs 150+/-54 minutes, p < 0.03) and ACC time (151+/-38 vs 96+/-40 minutes, p < 0.02) was longer in the nonsurvivor group. In the group with chronic passive congestion, the postoperative course of 5 of 16 (31.3%) patients with valvular disease was poor. Serum cholinesterase concentration was lower only in the nonsurvivor group (nonsurvivor vs survivors: 2006+/-435 vs 3483+/-1442 IU/L, p < 0.02), and all patients with cholinesterase < 2000 IU/L died. Postoperative bleeding was greater in the nonsurvivor group (3327+/-2106 vs 1428+/-643 mL, p < 0.05). Multivariate logistic regression analysis including the described pre- and intraoperative factors identified only serum cholinesterase concentration (F = 9.18) as significant.
CONCLUSIONS: A low value of preoperative serum cholinesterase (< 2,000 IU/L) is thought to be the predictor of prognosis after open heart surgery in patients with severe posthepatitis and congestive liver dysfunction. Operative factors (cardiopulmonary time in posthepatitis liver dysfunction and postoperative bleeding in the congestive liver dysfunction) also influenced the prognosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10789703     DOI: 10.1111/j.1540-8191.1999.tb00973.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  5 in total

1.  Preoperative evaluation using asialoscintigraphy in patients undergoing cardiac surgery with noncardiac liver cirrhosis.

Authors:  Yoshiyuki Takami; Hiroshi Masumoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-11

2.  Prediction of postoperative hepatic dysfunction after cardiac surgery in patients with chronic congestive heart failure.

Authors:  Hiroyuki Nishi; Toshiki Takahashi; Hajime Ichikawa; Goro Matsumiya; Hikaru Matsuda; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-07-14

3.  Preoperative evaluation of patients with liver cirrhosis undergoing open heart surgery.

Authors:  Takashi Murashita; Tatsuhiko Komiya; Nobushige Tamura; Genichi Sakaguchi; Taira Kobayashi; Tomokuni Furukawa; Akihito Matsushita; Gengo Sunagawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-06-17

4.  Preoperative assessment of congestive liver dysfunction using technetium-99 m galactosyl human serum albumin liver scintigraphy in patients with severe valvular heart disease.

Authors:  Hiroyuki Nishi; Toshiki Takahashi; Goro Matsumiya; Hiroshi Takano; Hajime Ichikawa; Shigeru Miyagawa; Yoshiki Sawa
Journal:  Surg Today       Date:  2007-06-26       Impact factor: 2.549

5.  Prediction of outcome in patients with liver dysfunction after left ventricular assist device implantation.

Authors:  Hiroyuki Nishi; Koichi Toda; Shigeru Miyagawa; Yasushi Yoshikawa; Satsuki Fukushima; Daisuke Yoshioka; Tetsuya Saito; Shunsuke Saito; Taichi Sakaguchi; Takayoshi Ueno; Toru Kuratani; Yoshiki Sawa
Journal:  J Artif Organs       Date:  2013-08-29       Impact factor: 1.731

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.